Friday, March 14, 2025

Creating liberating content

Oracle Corp’s (NYSE: ORCL)...

Oracle Corp (NYSE: ORCL) falls down to its knees, share dropped over 12.15%...

RTX Corp (NYSE: RTX)...

RTX Corp (NYSE: RTX) experienced a notable decline of -7.22%, amounting to $6.03...

GameStop Corp. (NYSE:GME) Quarter...

GameStop Corp. (NYSE: GME) to announce its second quarter fiscal 2023 results after...

Advanced Micro Devices (NASDAQ:AMD)...

Shares of Advanced Micro Devices (NASDAQ:AMD) drops 0.38% in afterhours in last trading...
HomeTagsMirati Therapeutics' KRAZATI approval FDA

Tag: Mirati Therapeutics' KRAZATI approval FDA

Mirati Therapeutics, Inc. (NASDAQ: MRTX)...

A targeted oncology company, Mirati Therapeutics, Inc....

Mirati Therapeutics, Inc. (NASDAQ: MRTX) Jumps FDA Has Given Expedited Clearance to KRAZATI

A targeted oncology company, Mirati Therapeutics, Inc. (NASDAQ: MRTX) jumps over 15.43% in early trading session on Tuesday after the FDA has given expedited clearance to KRAZATI (adagrasib), a targeted therapeutic option for adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as established by an FDA-approved test, who have undergone at least one previous systemic therapy. The CEO, Mirati Therapeutics, Inc., David Meek stated that the FDA approval of KRAZATI is a significant step forward for thousands of patients who have KRASG12C mutations, including roughly...

Mirati Therapeutics, Inc....

A targeted oncology company, Mirati Therapeutics, Inc. (NASDAQ: MRTX) jumps over 15.43% in early trading session on Tuesday after the FDA has given expedited...
spot_img

Create a website from scratch

With Newspaper Theme you can drag and drop elements onto a page and customize them to perfection. Try it out today and create the perfect site to express yourself!